Evaluation of factors influencing long-term and textbook outcomes in laparoscopic gastrectomy

Lin, Xia; Tan, Chenjun; Wu, Weigao; Liang, Chenglong; Qian, Feng; Zhao, Yongliang

doi:10.1016/j.ejso.2024.108002

Cited by 2 publications

(1 citation statement)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the context of GC surgery, the textbook outcome (TO) is a multifaceted indicator of surgical quality. The application of TO in laparoscopic gastrectomy establishes a standard for attaining better prognoses and enables surgeons to devise methods to enhance surgical care [70].…”

Section: Surgery and Immunonutritionmentioning

confidence: 99%

Prognosis and Treatment of Gastric Cancer: A 2024 Update

Burz,

Pop,

Silaghi

et al. 2024

Cancers

View full text Add to dashboard Cite

Due to the high death rate associated with gastric cancer, a great deal of research has been conducted on this disease. The goal of this paper was to start a trimestral review of 2024 for the year that had just started. The scientific literature from 1 January 2024 was chosen with consideration of the the guidelines of the European Society of Medical Oncology (ESMO), which are updated with new findings but not systematically reviewed annually. We used the search term “gastric cancer” to find the most current publications in the PubMed database related to the prognosis and treatment of gastric cancer. As previously said, the only articles that satisfied the inclusion criteria were those from 2024. Articles with case reports were eliminated since they had nothing to do with our research. The treatment of gastric cancer is the focus of the majority of articles from 2024. The primary research axes include surgery and immunonutrition, immunotherapy and Helicobacter pylori, and therapeutic targets. Patients with GC may experience less psychological, social, and financial hardship if the recently identified markers discovered in circulation are better assessed and validated. This could be achieved by either including the markers in an artificial intelligence-based diagnostic score or by using them in conjunction with traditional diagnostic methods. Due to the rising death rate associated with GC, funding for research into diagnosis, prognosis, therapy, and therapeutic targets is essential.

show abstract

Section: Surgery and Immunonutritionmentioning

confidence: 99%